First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses.
about
Simultaneous fMRI-PET of the opioidergic pain system in human brainPET/MRI in Oncological Imaging: State of the ArtApplication of positron emission tomography/computed tomography in radiation treatment planning for head and neck cancersNon-invasive diagnostic imaging of colorectal liver metastasesCurrent Status of Hybrid PET/MRI in Oncologic ImagingClinical and research applications of simultaneous positron emission tomography and MRICholine metabolism-based molecular diagnosis of cancer: an updateVision 20/20: Magnetic resonance imaging-guided attenuation correction in PET/MRI: Challenges, solutions, and opportunitiesRecent Advances in Higher-Order, Multimodal, Biomedical Imaging Agents.Multimodality molecular imaging of the lung.Effect of MRI acoustic noise on cerebral fludeoxyglucose uptake in simultaneous MR-PET imaging.PET/MRI for neurologic applications.Does PET/MR in human brain imaging provide optimal co-registration? A critical reflection.Is there a role for PET-CT and SPECT-CT in pediatric oncology?Evaluation of Dixon Sequence on Hybrid PET/MR Compared with Contrast-Enhanced PET/CT for PET-Positive Lesions.Clinical applications of PET/MRI: current status and future perspectives.Simultaneous PET/MRI: Impact on cancer management-A comprehensive review of casesMultiparametric analysis of bone marrow in cancer patients using simultaneous PET/MR imaging: Correlation of fat fraction, diffusivity, metabolic activity, and anthropometric data.Quantitative carotid PET/MR imaging: clinical evaluation of MR-Attenuation correction versus CT-Attenuation correction in (18)F-FDG PET/MR emission data and comparison to PET/CTContinuous MR bone density measurement using water- and fat-suppressed projection imaging (WASPI) for PET attenuation correction in PET-MRQuality control for quantitative multicenter whole-body PET/MR studies: A NEMA image quality phantom study with three current PET/MR systems.Metal artifact reduction in patients with dental implants using multispectral three-dimensional data acquisition for hybrid PET/MRIMR Imaging-Guided Attenuation Correction of PET Data in PET/MR Imaging.Comparison of Whole-Body (18)F FDG PET/MR Imaging and Whole-Body (18)F FDG PET/CT in Terms of Lesion Detection and Radiation Dose in Patients with Breast Cancer.Correlation Between Apparent Diffusion Coefficients and Standardized Uptake Values in Hybrid (18)F-FDG PET/MR: Preliminary Results in Rectal Cancer.PET/CT in Oncology: Current Status and Perspectives.Imaging in head and neck squamous cell carcinoma: the potential role of PET/MRI.Bias atlases for segmentation-based PET attenuation correction using PET-CT and MR.18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine.Positron Emission Tomography (PET) in OncologyDisruption of thalamic functional connectivity is a neural correlate of dexmedetomidine-induced unconsciousness.Integrated whole body MR/PET: where are we?Positron emission tomography/computed tomography for bone tumors (Review).In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma.Whole-Body PET/MR Imaging: Quantitative Evaluation of a Novel Model-Based MR Attenuation Correction Method Including BonePET/MRI for the evaluation of patients with lymphoma: initial observations.Preoperative staging of non-small cell lung cancer: prospective comparison of PET/MR and PET/CT.NEMA image quality phantom measurements and attenuation correction in integrated PET/MR hybrid imagingEffects of ferumoxytol on quantitative PET measurements in simultaneous PET/MR whole-body imaging: a pilot study in a baboon model.The contribution of Medical Physics to Nuclear Medicine: looking back - a physicist's perspective
P2860
Q24580478-95B90067-22FF-4E8C-8544-C46F05A683CFQ26768474-FC077B2C-818E-47D6-B431-5C9F69DF304CQ26773647-6DBAFFF9-8F41-4AB4-875F-60E45563343CQ26798428-4045C174-619C-45AF-BAC9-27C6BBCB27D8Q26825265-C92738D3-4405-455A-942E-3596E0DAF145Q26998774-FD6A5A55-9B0E-490A-91C3-1163F48A3E56Q27024079-3A570684-D710-45B0-ABC8-05A4B88DEB34Q28074576-489C6145-CF65-48F4-9F73-8EBC3ACBA0D1Q28085447-C0C9CCB4-D2C2-467C-A6A0-B593C2EABF42Q30364295-F5CE3FB8-91D1-40D3-A74A-F0DCCFCAF889Q30439116-8364EAFD-86D1-498D-8B9E-4A6CD5508D0FQ30577115-B666CEFB-6368-451D-9A7C-0724F3601C03Q30585141-CC134291-2716-4B3F-BCC9-03FCE3813C07Q30586066-56946F66-4F48-477C-B1FF-24FD68EE06F1Q30829156-33589988-4338-4890-AFC6-3DF28C3BF2F5Q30835897-EE2A1C39-1523-4052-95EE-AC4CF37CF3B3Q30836539-9CCDB949-B5DA-4A38-9C17-AF9CE4BD1519Q30893102-DF63A4D2-D20D-43AF-AAD0-D1788F5E453EQ30970716-D4FACD2D-B719-4AF2-A199-FD496D54B9B5Q30997197-B8552A9A-CA43-4815-9A20-C3D85DB922F3Q31000575-80245F46-D18C-4695-9529-8AD01EC8BB96Q31011095-6F50BAEA-81AF-46D1-BC6E-2B9AAC885391Q31054295-F14C222E-412B-4A25-A7E6-C96977A00630Q31064473-CE6EA086-E6E4-4C8B-96E9-07FFAB212F42Q31106473-9C5B5561-F943-4335-96AF-C0E1156496BAQ33665109-FFF5557D-A697-4547-A537-B9120266A155Q33792289-8126AE79-A23B-4338-A011-2B4F41D67151Q33792357-4E134831-A83E-4FF2-A474-5FFF8CCBD214Q33880479-9F6BAD08-8A2B-4138-AE94-40A0C517DC69Q34774840-0634A81F-961B-490E-9F52-C71ECDCB16A6Q34792702-0AD9E298-BEB9-4BCD-86A6-605384E236C7Q34975185-212F548F-02C3-49B5-8788-6FCFB56EC9F1Q34993781-4D5030DF-9E2C-4268-A716-80AA401BEC81Q35483867-A0B1748B-D552-40E6-AB0C-8ADA3B7B6B5FQ35646866-2B1BCED4-8A73-440A-8AB5-DB61EF2E05FDQ35737190-CC04A2F7-84C1-464B-B000-80D6B923DD71Q35925339-7AA08259-D2D9-47F3-903D-5E39624F22BCQ35975395-8A3B765B-3FD0-47AC-995F-A38CA9FA79D9Q35981341-3CAFC36A-CBFB-4C76-81DC-D75FDC2012ACQ35985107-F9D62B9C-C256-4563-A9A5-7DA074831637
P2860
First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
First clinical experience with ...... ents with oncologic diagnoses.
@en
First clinical experience with ...... ents with oncologic diagnoses.
@nl
type
label
First clinical experience with ...... ents with oncologic diagnoses.
@en
First clinical experience with ...... ents with oncologic diagnoses.
@nl
prefLabel
First clinical experience with ...... ents with oncologic diagnoses.
@en
First clinical experience with ...... ents with oncologic diagnoses.
@nl
P2093
P50
P1476
First clinical experience with ...... ents with oncologic diagnoses.
@en
P2093
Ambros J Beer
Axel Martinez-Möller
Ernst J Rummeny
Matthias Eiber
Michael Souvatzoglou
Sebastian Fürst
Sibylle Ziegler
Stephan G Nekolla
P304
P356
10.2967/JNUMED.111.098608
P407
P577
2012-04-25T00:00:00Z